Limits...
Exposure levels of environmental endocrine disruptors in mother-newborn pairs in China and their placental transfer characteristics.

Li LX, Chen L, Meng XZ, Chen BH, Chen SQ, Zhao Y, Zhao LF, Liang Y, Zhang YH - PLoS ONE (2013)

Bottom Line: The placenta is expected to be an effective barrier protecting the developing embryo against some endocrine disruptors (EDs) circulating in maternal blood.In contrast, PBDEs levels in cord blood samples were significantly higher than those in maternal blood.MEHP levels in meconium were much higher than those in cord blood samples, and highly correlated.

View Article: PubMed Central - PubMed

Affiliation: Key Laboratory of Public Health Safety, Ministry of Education, School of Public Health, Fudan University, Shanghai, China.

ABSTRACT
There is a growing concern about the potential health effects of exposure to various environmental chemicals during pregnancy and infancy. The placenta is expected to be an effective barrier protecting the developing embryo against some endocrine disruptors (EDs) circulating in maternal blood. The current study was designed to assess in utero exposure levels of non-persistent organic pollutants (non-POPs) and persistent organic pollutants (POPs) in Chinese newborns and potential role of placenta barrier against fetal exposure to these commonly-used environmental endocrine disruptors. A total of 230 newborn-mother pairs were enrolled during 2010-2011, 201 pairs of which were recruited from Shanghai, and the other 29 pairs came from Wenzhou. Maternal blood, cord blood, and meconium specimens were collected in the subject population from Shanghai and analyzed for non-POPs, including mono-2-ethylhexyl phthalate (MEHP), octylphenol (OP) and 4-nonylphenol (4-NP). A total of 19 polybrominated diphenyl ethers (PBDEs) congeners, which belong to POPs, were detected in maternal and cord blood specimens from the other 29 pairs. Fetal-maternal ratios (F-M ratios) and regression coefficients were presented to assess potential function of placenta on barricading the mother/fetal transfer of these EDs. Concentrations of the detected non-POPs in cord blood samples were approximately 20% lower than those in maternal blood, and regression coefficients of which were all over 0.80. In contrast, PBDEs levels in cord blood samples were significantly higher than those in maternal blood. MEHP levels in meconium were much higher than those in cord blood samples, and highly correlated. Therefore, observations demonstrated that the placental barrier slightly decreased the fetal exposure to most non-POPs, while PBDEs seemed to be totally transferred across the placenta and finally reached the fetus. For in utero exposure assessment of Di-2-ethylhexyl phthalate (DEHP), MEHP level in meconium may be a useful biomarker.

Show MeSH

Related in: MedlinePlus

Correlation between MEHP levels in cord blood and in meconium.MEHP was detected in 135 of 201 mother-newborn pairs, presenting a good correlation in cord blood and meconium.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3646826&req=5

pone-0062526-g005: Correlation between MEHP levels in cord blood and in meconium.MEHP was detected in 135 of 201 mother-newborn pairs, presenting a good correlation in cord blood and meconium.

Mentions: MEHP was detected in 135 of 201 mother-newborn pairs, presenting a good correlation in cord blood and meconium (Figure 5). And figure 6 showed the frequency distribution of MEHP levels in cord blood and meconium, illustrating that MEHP levels in meconium were much higher than those in cord blood.


Exposure levels of environmental endocrine disruptors in mother-newborn pairs in China and their placental transfer characteristics.

Li LX, Chen L, Meng XZ, Chen BH, Chen SQ, Zhao Y, Zhao LF, Liang Y, Zhang YH - PLoS ONE (2013)

Correlation between MEHP levels in cord blood and in meconium.MEHP was detected in 135 of 201 mother-newborn pairs, presenting a good correlation in cord blood and meconium.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3646826&req=5

pone-0062526-g005: Correlation between MEHP levels in cord blood and in meconium.MEHP was detected in 135 of 201 mother-newborn pairs, presenting a good correlation in cord blood and meconium.
Mentions: MEHP was detected in 135 of 201 mother-newborn pairs, presenting a good correlation in cord blood and meconium (Figure 5). And figure 6 showed the frequency distribution of MEHP levels in cord blood and meconium, illustrating that MEHP levels in meconium were much higher than those in cord blood.

Bottom Line: The placenta is expected to be an effective barrier protecting the developing embryo against some endocrine disruptors (EDs) circulating in maternal blood.In contrast, PBDEs levels in cord blood samples were significantly higher than those in maternal blood.MEHP levels in meconium were much higher than those in cord blood samples, and highly correlated.

View Article: PubMed Central - PubMed

Affiliation: Key Laboratory of Public Health Safety, Ministry of Education, School of Public Health, Fudan University, Shanghai, China.

ABSTRACT
There is a growing concern about the potential health effects of exposure to various environmental chemicals during pregnancy and infancy. The placenta is expected to be an effective barrier protecting the developing embryo against some endocrine disruptors (EDs) circulating in maternal blood. The current study was designed to assess in utero exposure levels of non-persistent organic pollutants (non-POPs) and persistent organic pollutants (POPs) in Chinese newborns and potential role of placenta barrier against fetal exposure to these commonly-used environmental endocrine disruptors. A total of 230 newborn-mother pairs were enrolled during 2010-2011, 201 pairs of which were recruited from Shanghai, and the other 29 pairs came from Wenzhou. Maternal blood, cord blood, and meconium specimens were collected in the subject population from Shanghai and analyzed for non-POPs, including mono-2-ethylhexyl phthalate (MEHP), octylphenol (OP) and 4-nonylphenol (4-NP). A total of 19 polybrominated diphenyl ethers (PBDEs) congeners, which belong to POPs, were detected in maternal and cord blood specimens from the other 29 pairs. Fetal-maternal ratios (F-M ratios) and regression coefficients were presented to assess potential function of placenta on barricading the mother/fetal transfer of these EDs. Concentrations of the detected non-POPs in cord blood samples were approximately 20% lower than those in maternal blood, and regression coefficients of which were all over 0.80. In contrast, PBDEs levels in cord blood samples were significantly higher than those in maternal blood. MEHP levels in meconium were much higher than those in cord blood samples, and highly correlated. Therefore, observations demonstrated that the placental barrier slightly decreased the fetal exposure to most non-POPs, while PBDEs seemed to be totally transferred across the placenta and finally reached the fetus. For in utero exposure assessment of Di-2-ethylhexyl phthalate (DEHP), MEHP level in meconium may be a useful biomarker.

Show MeSH
Related in: MedlinePlus